Improving the number of women and other underrepresented groups in clinical trials is essential for achieving health equity. Dr. Rose Blackburne, MD, MBA, President, Medical Science and Strategy, and Global Head of General Medicine and Women’s Health, kicks off the third season of our #ScienceWithATwist podcast to explain the critical need for diversity in clinical trials, the history behind it, and why it’s important to expand research related to women beyond reproductive health. To learn more about the challenges, solutions, and recent advancements in clinical trial recruitment efforts, listen to the full discussion: https://lnkd.in/gbyGJCwx
So honored to have Rose as a colleague. Supporting women’s health.
Totally support, women health is beyond reproductive and it is very long waited time to bring therapeutic options with focus on women. Will bookmark this, Rose!
Lecturer/ haematology blood transfusion Science at Babcock University Nigeria.Chair impact for all foundation
5dWomen Inclusiveness in such trials is essential for full representative participation and engagement